What was the study conclusion? APHAs were more likely than non-APHAs to be diagnosed with HIV with a cell count less than 200 cells/mL. Time of diagnosis among APHAs and non-APHA did not appear to differ however when compared by AIDS-defining illness.
Why is this question important?
Late diagnosis of HIV can have negative consequences on the health status of an individual living with HIV, including greater likelihood of illness and death. Research has also shown that late HIV diagnosis can contribute to increased health care costs. Other benefits of early diagnosis can include more opportunity to offer HIV treatment and other behavioural interventions, therefore reducing the risk of onward HIV transmission.
How was the study conducted?
Data from participants of the OCS who reported information on their ethnicity were used in this study. Statistical analyses were performed on the results reported by these participants to identify if there were differences in the time of diagnoses between the two populations of PHAs (Aboriginal and non-Aboriginal), and to identify if that difference was significant, and why.
What were the main results of the study? While there were differences in CD4 counts at diagnosis between APHAs and non-APHAs, the analysis did not show that APHAs were being diagnosed with HIV later than non-APHAs when measured by a diagnosis of an AIDS-defining illness. The difference in these findings may indicate that CD4 count is a more useful measurement for late HIV diagnosis, especially among populations who may be underserved by health services.
